Methods to Assess Melatonin Receptor-Mediated Phase-Shift and Re-entrainment of Rhythmic Behaviors in Mouse Models
- 1 October 2022
- book chapter
- Published by Springer Nature
- Vol. 2550, 391-411
Abstract
The neurohormone melatonin facilitates entrainment of biological rhythms to environmental light-dark conditions as well as phase-shifts of circadian rhythms in constant conditions via activation of the MT1 and/or MT2 receptors expressed within the suprachiasmatic nucleus of the hypothalamus. The efficacy of melatonin and related agonists to modulate biological rhythms can be assessed using two well-validated mouse models of rhythmic behaviors. These models serve as predictive measures of therapeutic efficacy for treatment of circadian phase disorders caused by internal (e.g., clock gene mutations, blindness, depression, seasonal affective disorder) or external (e.g., shift work, travel across time zones) causes in humans. Here we provide background and detailed protocols for quantitative assessment of the magnitude and efficacy of melatonin receptor ligands in mouse circadian phase-shift and re-entrainment paradigms. The utility of these models in the discovery of novel therapeutics acting on melatonin receptors will also be discussed. Key words Melatonin Melatonin receptors Phase-shift Entrainment Jet lag Rhythmic behaviorsKeywords
This publication has 81 references indexed in Scilit:
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin ReceptorsPharmacological Reviews, 2010
- The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitnessBiological Reviews, 2010
- Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?British Journal of Pharmacology, 2008
- A three pulse phase response curve to three milligrams of melatonin in humansThe Journal of Physiology, 2008
- Melatonin in the skin: synthesis, metabolism and functionsTrends in Endocrinology & Metabolism, 2008
- Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down‐regulationJournal of Pineal Research, 2007
- Melatonin Entrains Free‐running Blind People According to a Physiological Dose‐response CurveChronobiology International, 2005
- Short-Term Exposure to Melatonin Differentially Affects the Functional Sensitivity and Trafficking of the hMT1 and hMT2 Melatonin ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Phase angle changes of photically entrained circadian rhythms following a single nonphotic stimulusPhysiology & Behavior, 1994
- Melatonin Receptor Sites in the Syrian Hamster Brain and Pituitary. Localization and Characterization Using [125|]lodomelatonin*Journal of Neuroendocrinology, 1989